ABN AMRO Bank N.V. Buys 36,950 Shares of MetLife, Inc. $MET

ABN AMRO Bank N.V. lifted its position in MetLife, Inc. (NYSE:MET) by 1.7% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 2,246,170 shares of the financial services provider’s stock after buying an additional 36,950 shares during the period. MetLife accounts for 1.8% of ABN AMRO Bank N.V.’s portfolio, making the stock its 20th biggest position. ABN AMRO Bank N.V.’s holdings in MetLife were worth $184,359,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in MET. HighPoint Advisor Group LLC increased its holdings in MetLife by 1.9% during the third quarter. HighPoint Advisor Group LLC now owns 19,177 shares of the financial services provider’s stock valued at $1,580,000 after buying an additional 349 shares during the period. Linscomb Wealth Inc. boosted its position in MetLife by 0.5% during the 3rd quarter. Linscomb Wealth Inc. now owns 124,759 shares of the financial services provider’s stock valued at $10,276,000 after acquiring an additional 579 shares in the last quarter. Bessemer Group Inc. increased its holdings in shares of MetLife by 0.5% in the 3rd quarter. Bessemer Group Inc. now owns 1,979,898 shares of the financial services provider’s stock valued at $163,085,000 after acquiring an additional 9,462 shares during the period. Savant Capital LLC raised its position in shares of MetLife by 27.1% in the 3rd quarter. Savant Capital LLC now owns 31,537 shares of the financial services provider’s stock worth $2,598,000 after acquiring an additional 6,734 shares in the last quarter. Finally, Unison Advisors LLC lifted its stake in shares of MetLife by 0.7% during the 3rd quarter. Unison Advisors LLC now owns 53,182 shares of the financial services provider’s stock worth $4,381,000 after purchasing an additional 377 shares during the last quarter. 94.99% of the stock is currently owned by institutional investors.

MetLife Trading Up 1.5%

Shares of MET stock opened at $78.07 on Thursday. MetLife, Inc. has a fifty-two week low of $65.21 and a fifty-two week high of $87.39. The firm has a market capitalization of $51.44 billion, a P/E ratio of 14.70, a PEG ratio of 0.73 and a beta of 0.77. The stock’s fifty day moving average is $78.92 and its two-hundred day moving average is $78.84. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.18 and a current ratio of 0.18.

MetLife (NYSE:MET) last posted its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.58 EPS for the quarter, beating the consensus estimate of $2.38 by $0.20. MetLife had a return on equity of 21.00% and a net margin of 5.30%.The firm had revenue of $18.61 billion during the quarter, compared to analysts’ expectations of $31.43 billion. During the same quarter last year, the firm earned $2.08 earnings per share. The business’s revenue for the quarter was up 27.6% on a year-over-year basis. Research analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 10th. Shareholders of record on Tuesday, February 3rd will be issued a dividend of $0.5675 per share. The ex-dividend date is Tuesday, February 3rd. This represents a $2.27 dividend on an annualized basis and a yield of 2.9%. MetLife’s dividend payout ratio is 42.75%.

Analysts Set New Price Targets

Several equities analysts have issued reports on MET shares. Mizuho set a $102.00 price target on shares of MetLife in a report on Wednesday, January 14th. Wells Fargo & Company raised their price objective on MetLife from $94.00 to $97.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 13th. Keefe, Bruyette & Woods reduced their target price on MetLife from $92.00 to $90.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 11th. Evercore ISI set a $97.00 price target on MetLife and gave the stock an “in-line” rating in a report on Tuesday, January 6th. Finally, Weiss Ratings restated a “buy (b-)” rating on shares of MetLife in a research note on Monday, December 29th. Two investment analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $95.27.

Key Stories Impacting MetLife

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: Adjusted results beat expectations: MetLife reported adjusted Q4 EPS above consensus and highlighted full‑year adjusted EPS growth and momentum, supporting the company’s profit story. MetLife Announces Full Year and 4Q 2025 Results
• Positive Sentiment: Investment returns helped adjusted quarterly profit rise, a driver for underwriting and investment‑led income that investors view positively. Insurer MetLife Adjusted Quarterly Profit Rises on Strong Investment Returns
• Positive Sentiment: Business mix strength: management cited group benefits and Retirement & Income Solutions (RIS) as contributors to Q4 performance, indicating durable segment-level momentum. MetLife Q4 earnings strengthened by group benefits, RIS units
• Positive Sentiment: Analyst / market commentary sees overall 2025 strength and growth momentum, which can support longer‑term upside versus current multiples. MetLife Reports Strong 2025 Results and Growth Momentum
• Neutral Sentiment: Company provided a CFO video update and slide deck to clarify results and segmentation — useful context but not new guidance. MetLife CFO John McCallion Provides Fourth Quarter and Full Year 2025 Financial Update Video
• Neutral Sentiment: Wider coverage on employee financial wellbeing (MetLife research) and brand recognition may support long‑term franchise value but have limited immediate market impact. The decade that broke employee financial wellbeing, according to MetLife
• Neutral Sentiment: Earnings preview / regional risk watch: analysts are focused on whether Asia growth can offset credit headwinds — a watch item for guidance and reserve assumptions. MetLife earnings on deck: Can Asia growth offset credit headwinds?
• Negative Sentiment: Revenue reporting missed some market estimates: headlines note Q4 revenue came in below certain consensus figures, which raises questions about comparability of metrics reported (PFOs vs. broader revenue measures). MetLife (NYSE: MET) misses Q4 CY2025 revenue estimates
• Negative Sentiment: Third‑party bulletin flagged a significant GAAP EPS and revenue miss (reports a lower diluted EPS and revenues vs. some estimates); the provider notes figures are unverified, but the note likely amplified market concern about GAAP vs. adjusted results. MetLife (MET) Releases Q4 2025 Earnings: Revenue Growth but EPS Miss

MetLife Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.